Louis J. Aronne is in the news for his expertise on weight-loss drugs like Ozempic and Wegovy, building on his reputation as a top obesity specialist.
Recent developments include Eli Lilly's oral drug Orforglipron, which completed phase 3 trials showing comparable results to injections like Mounjaro. Meanwhile, UK patients face rising costs for treatments, and stories highlight personal weight-loss journeys and access challenges amid price hikes and shortages.